Literature DB >> 18034972

Atopic dermatitis and asthma.

Elena Galli1, Simona Gianni, Giovanni Auricchio, Ercole Brunetti, Giorgio Mancino, Paolo Rossi.   

Abstract

Atopic dermatitis (AD), a chronic inflammatory skin disease, frequently associated with respiratory allergy, is one of the most common skin disorders observed in children. The prevalence of AD and other allergic diseases is increasing in industrialized countries, representing a major burden on health care cost. AD has been proposed as an "entry point" for subsequent allergic diseases, suggesting the possibility that effective management of AD could prevent the development of respiratory allergy or at least reduce the severity of asthma and allergic rhinitis. AD and asthma share a common genetic and pathogenic basis, and several longitudinal studies provided evidence for the atopic march from AD to allergic rhinitis and asthma. However, because only a few prospective studies starting at children's births and having a sufficiently long follow-up have been developed, little is known about the natural course of AD and the potential succession of atopic phenotypes in childhood. Finally, recent genetic and epidemiological data raised the question whether AD may either develop to asthma or be part of a syndrome consisting of both diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18034972     DOI: 10.2500/aap2007.28.3048

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  10 in total

1.  Study of the Atopic March: Development of Atopic Comorbidities.

Authors:  Lynda Schneider; Jon Hanifin; Mark Boguniewicz; Lawrence F Eichenfield; Jonathan M Spergel; Rada Dakovic; Amy S Paller
Journal:  Pediatr Dermatol       Date:  2016-06-07       Impact factor: 1.588

2.  The associations of triclosan and paraben exposure with allergen sensitization and wheeze in children.

Authors:  Adam J Spanier; Tracy Fausnight; Tareq F Camacho; Joseph M Braun
Journal:  Allergy Asthma Proc       Date:  2014 Nov-Dec       Impact factor: 2.587

3.  GENEASE: real time bioinformatics tool for multi-omics and disease ontology exploration, analysis and visualization.

Authors:  Sudhir Ghandikota; Gurjit K Khurana Hershey; Tesfaye B Mersha
Journal:  Bioinformatics       Date:  2018-09-15       Impact factor: 6.937

4.  Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy.

Authors:  Alon Y Hershko; Nicolas Charles; Ana Olivera; Damiana Alvarez-Errico; Juan Rivera
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

5.  Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.

Authors:  Rosalind J Wright; Cynthia M Visness; Agustin Calatroni; Mitchell H Grayson; Diane R Gold; Megan T Sandel; Aviva Lee-Parritz; Robert A Wood; Meyer Kattan; Gordon R Bloomberg; Melissa Burger; Alkis Togias; Frank R Witter; Rhoda S Sperling; Yoel Sadovsky; James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

Review 6.  The atopic march: what's the evidence?

Authors:  Jennifer Ker; Tina V Hartert
Journal:  Ann Allergy Asthma Immunol       Date:  2009-10       Impact factor: 6.347

Review 7.  Atopic Dermatitis and Respiratory Allergy: What is the Link.

Authors:  Danielle C M Belgrave; Angela Simpson; Iain E Buchan; Adnan Custovic
Journal:  Curr Dermatol Rep       Date:  2015-09-28

8.  Adult Atopic Dermatitis with Comorbid Atopic Disease is Associated with Increased Risk of Infections: A Population-Based Cross-Sectional Study.

Authors:  Saisindhu Narala; Tissa R Hata
Journal:  Dermatol Ther (Heidelb)       Date:  2017-01-30

9.  Measuring the importance of vertices in the weighted human disease network.

Authors:  Seyed Mehrzad Almasi; Ting Hu
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

10.  Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma.

Authors:  Shadmehr Demehri; Mitsuru Morimoto; Michael J Holtzman; Raphael Kopan
Journal:  PLoS Biol       Date:  2009-05-19       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.